← Eichor
Condition: Clinically Significant Prostate Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Clinically Significant Prostate Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targe
NA · 1 location(s) · Jules Bordet Institute · NCT06867588Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Phase N/A · 9 location(s) · Xijing Hospital · NCT07553780Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
Phase 2 · 1 location(s) · IRCCS San Raffaele · NCT06305390POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions
Phase 2 · 1 location(s) · University of Florida · NCT07220720Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
NA · 1 location(s) · Washington University School of Medicine · NCT07109427Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
EARLY_Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07164027INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NA · 1 location(s) · In Gab Jeong, MD · NCT07398690The Development and Validation of MRI-AI-based Predictive Models for csPCa
Phase N/A · 1 location(s) · Peking University First Hospital · NCT06842264Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial
NA · 1 location(s) · Chinese University of Hong Kong · NCT06303622Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Phase N/A · 1 location(s) · Virdx, Inc. · NCT07432360Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer
NA · 1 location(s) · Salzburger Landeskliniken · NCT06579911MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT03819751Transperineal Versus Transrectal Cognitive Fusion Prostate Biopsy
NA · 1 location(s) · Ankara Etlik City Hospital · NCT07710807Stratagen Quantitative Prostate MRI Platform Pilot Study
NA · 2 location(s) · Stratagen Bio, Inc. · NCT06985238Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Phase N/A · 10 location(s) · Xijing Hospital · NCT07492927Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06774781Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Pro
Phase N/A · 9 location(s) · Xijing Hospital · NCT07531329Investigation of Three Biomarkers for the Detection of Prostate Cancer
Phase N/A · 1 location(s) · Medtechtomarket Consulting Ltd · NCT06554587Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
Phase N/A · 1 location(s) · Guangxi Medical University · NCT07614256Validation of a Machine Learning Model Based on MR for the Prediction of Prostate Cancer
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06773598Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance
Phase N/A · 10 location(s) · Istanbul University - Cerrahpasa · NCT07168616
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.